The dosage regimen of levamisole in cancer: Is it related to efficacy and safety?
- 31 December 1983
- journal article
- review article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 5 (1), 1-9
- https://doi.org/10.1016/0192-0561(83)90065-6
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Levamisole and Immunotherapy: Some Theoretic and Practical Considerations and Their Relevance to Human DiseaseOncology, 1981
- A randomized study of adjuvant immunotherapy with levamisole and corynebacterium parvum in operable non-small cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 1980
- An Overview of the Current Status of Levamisole in the Treatment of Rheumatic DiseasesDrugs, 1980
- Actinomycin-D, levamisole chemoimmunotherapy of refractory malignant melanomaCancer, 1979
- Combined chemoimmunotherapy for advanced breast cancer.A comparison of BCG and levamisoleCancer, 1979
- Levamisole and surgery in bronchial carcinoma patients: increase in deaths from cardiorespiratory failure.Thorax, 1979
- Immunokinetics of A Single Dose of LevamisoleJournal of Immunopharmacology, 1979
- Sequential chemoimmunotherapy of colorectal cancer. Evaluation of methotrexate, Baker's antifol and levamisoleCancer, 1978
- Clozapine-induced agranulocytosis: A situation report up to August 1976European Journal of Clinical Pharmacology, 1977
- Agranulocytosis during treatment with clozapineEuropean Journal of Clinical Pharmacology, 1977